Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stimulan Rapid Cure for Prevention of Breast Tissue Expander-Associated Infections
NCT07220967Phase 4Recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Oct 2025
- Primary completion
- Oct 2027
- Modality
- Nanoparticles, Implantable Devices, Cyclic Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of vancomycin, gentamicin in surgical site infection (SSI), sponsored by Memorial Sloan Kettering Cancer Center. Started Oct 2025; status: recruiting.
02
Drugs
vancomycingentamicin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT07220967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07220967.